Skip to main content
رجوع
Watch Compare

Edesa Biotech, Inc.

جودة البيانات: 83%
EDSA
Nasdaq Manufacturing Chemicals
KWD 5.52
▼ KWD 0.40 (-6.76%)
القيمة السوقية: 50.51 M
السعر
KWD 6.05
القيمة السوقية
50.51 M
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Negative free cash flow of -7.89 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-55.66%
أقل من متوسط القطاع (-53.41%)
ROIC-47.00%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio16.82
Interest CoverageN/A

التقييم

PE (TTM)
-6.46
أقل من متوسط القطاع (-1.48)
P/B Ratio3.62
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -6.5 -1.5
P/B 3.6 1.6
ROE % -55.7 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -7.82 M
ROE -55.66% ROA -52.96%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -7.89 M
ROIC -47.00% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 16.82
Interest Coverage N/A Asset Turnover N/A
Working Capital 11.96 M Tangible Book Value 12.00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.46 Forward P/E N/A
P/B Ratio 3.62 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -15.63%
Market Cap 50.51 M Enterprise Value 38.41 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0.95 OCF / Share -0.95
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 100.98%
SBC-Adj. FCF -8.62 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0.0
Net Income -7.19 M -6.17 M -8.37 M -17.55 M -13.34 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -7.91 M -7.01 M -9.22 M -18.37 M -23.68 M
EBITDA — — — — —
R&D Expenses 3.67 M 2.88 M 4.79 M 13.34 M 17.95 M
SG&A Expenses — — — — —
D&A 119,273.0 186,049.0 183,471.0 118,188.0 118,788.0
Interest Expense — — — — —
Income Tax 800.0 800.0 800.0 800.0 800.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13.53 M 3.81 M 8.89 M 11.58 M 14.58 M
Total Liabilities — 1.83 M 1.84 M 2.18 M 1.53 M
Shareholders' Equity 12.45 M 1.98 M 7.05 M 9.39 M 13.06 M
Total Debt — — — — —
Cash & Equivalents 10.80 M 1.00 M 5.40 M 7.09 M 7.84 M
Current Assets 11.51 M 1.68 M 6.44 M 9.09 M 12.09 M
Current Liabilities 1.08 M 1.83 M 1.82 M 2.14 M 1.46 M